圣诺医药-B
港股通 官网
( 02257.hk)
市盈率-8.35市净率-22.29股息率0%上市时间2021-12-30股价8.35港币涨跌幅1.95%成交金额70.90万港币换手率0.08%市值8.95亿港币H股市值8.95亿港币总股本1.07亿H股本1.07亿每手股数50上市至今年化投资收益率-42.24%港股通持仓占H股比例2.82% (2,654.98万港币2026-01-26)
所属三级行业生物技术 (恒生) 市盈率67.63市净率5.13股息率0.30%恒生:医疗保健业药品及生物科技生物技术
备注 (2): 双击编辑备注
发表讨论

圣诺医药-B(02257) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1戴曉暢Executive Director2022-07-19--
2華風茂Independent Non Executive Director2021-12-20--
3盛慕嫻Independent Non Executive Director - A/F2021-12-20--
4黃夢瑩Independent Non Executive Director2021-12-20--
5于常海Independent Non Executive Director2021-12-20--
6EVANS Mark DavidExecutive Director2021-07-12--
7章建康Non Executive Director2021-07-12--
8黃敏聰Non Executive Director2021-01-25--
9MOLYNEAUX Michael V.Executive Director2021-01-252023-11-30
10柳達Non Executive Director2021-01-252022-09-30
11賴嘉俊Non Executive Director2021-01-252022-08-31
12戴曉暢Non Executive Director2021-01-252022-07-19
13陸陽Executive DirectorChairman, CEO2020-10-15--